Published in Obesity and Diabetes Week, January 26th, 2004
In their study, G. Laverman and colleagues at Martini Hospital in Groningen evaluated the "beneficial effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on renal and cardiovascular outcomes", with "a particular focus on their optimal use in the hypertensive diabetic patient with or without evidence of renal or cardiovascular disease."
"Although the mechanism of action of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week